SCHEMBL30348056

SCHEMBL30348056

Cc1nc2ccc(-c3c[nH]c4nc(NCC5CCC(F)(F)CC5)ncc34)cc2s1

nearest known ligand 0.38

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 2/20 0.38
▸ DYRK2 Q92630 4/20 0.36
▸ ACP1 P24666 1/20 0.36
▸ ABL1 P00519 3/20 0.36
▸ DYRK1A Q13627 2/20 0.35
▸ HCRTR1 O43613 3/20 0.35
▸ PCSK9 Q8NBP7 1/20 0.34
▸ IRAK1 P51617 1/20 0.34
▸ USP30 Q70CQ3 1/20 0.34
▸ CLK2 P49760 1/20 0.34
▸ CLK3 P49761 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ DYRK1B Q9Y463 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25518089 1.00 BRD4 (0.38) BRD4DYRK2ACP1ABL1DYRK1A
SCHEMBL25214569 0.87 DYRK1A (0.43) BRD4DYRK2ACP1ABL1DYRK1A
SCHEMBL30348557 0.87 DYRK1A (0.43) BRD4DYRK2ACP1ABL1DYRK1A
SCHEMBL30348704 0.87 BRD4 (0.39) BRD4DYRK2ABL1DYRK1ACLK2
SCHEMBL25157917 0.87 BRD4 (0.39) BRD4DYRK2ABL1DYRK1ACLK2
SCHEMBL30348393 0.85 DYRK2 (0.40) BRD4DYRK2ACP1ABL1DYRK1A
SCHEMBL25200734 0.85 DYRK2 (0.40) BRD4DYRK2ACP1ABL1DYRK1A
SCHEMBL25157286 0.84 DYRK1A (0.40) BRD4ABL1DYRK1AIRAK1USP30
SCHEMBL30346905 0.84 DYRK1A (0.40) BRD4ABL1DYRK1AIRAK1USP30
SCHEMBL25158435 0.83 DYRK2 (0.39) BRD4DYRK2ACP1ABL1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4415818-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AS DYRK1A INHIBITORS BioSplice Therapeutics, Inc. (US) 2024-08-21 — — EP claimed
WO-2023064361-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AS DYRK1A INHIBITORS BIOSPLICE THERAPEUTICS, INC. (US) 2023-04-20 — — WO claimed
Send feedback